Bank of Montreal’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24M Buy
+493,743
New +$24M 0.01% 620
2024
Q4
Sell
-5,620
Closed -$266K 3222
2024
Q3
$266K Sell
5,620
-1,936
-26% -$91.6K ﹤0.01% 2556
2024
Q2
$473K Buy
7,556
+1,574
+26% +$98.4K ﹤0.01% 2190
2024
Q1
$434K Buy
5,982
+2,582
+76% +$187K ﹤0.01% 2256
2023
Q4
$233K Sell
3,400
-1,837
-35% -$126K ﹤0.01% 2622
2023
Q3
$267K Sell
5,237
-198
-4% -$10.1K ﹤0.01% 2498
2023
Q2
$322K Buy
+5,435
New +$322K ﹤0.01% 2526
2022
Q4
Sell
-3,904
Closed -$265 3496
2022
Q3
$265 Sell
3,904
-309
-7% -$21 ﹤0.01% 2604
2022
Q2
$313 Sell
4,213
-115,742
-96% -$8.6K ﹤0.01% 2596
2022
Q1
$7.75M Buy
119,955
+115,003
+2,322% +$7.43M ﹤0.01% 1039
2021
Q4
$397K Buy
4,952
+1,256
+34% +$101K ﹤0.01% 2497
2021
Q3
$416K Buy
3,696
+1,042
+39% +$117K ﹤0.01% 2785
2021
Q2
$387K Buy
2,654
+1,232
+87% +$180K ﹤0.01% 2834
2021
Q1
$171K Sell
1,422
-816
-36% -$98.1K ﹤0.01% 2813
2020
Q4
$423K Buy
2,238
+2,190
+4,563% +$414K ﹤0.01% 2388
2020
Q3
$4K Sell
48
-909
-95% -$75.8K ﹤0.01% 4070
2020
Q2
$90K Sell
957
-1,407
-60% -$132K ﹤0.01% 2782
2020
Q1
$93K Sell
2,364
-45,150
-95% -$1.78M ﹤0.01% 2347
2019
Q4
$2.89M Sell
47,514
-32,566
-41% -$1.98M ﹤0.01% 1436
2019
Q3
$3.28M Sell
80,080
-29,680
-27% -$1.22M ﹤0.01% 1196
2019
Q2
$5.17M Buy
109,760
+13,750
+14% +$648K ﹤0.01% 1037
2019
Q1
$3.43M Buy
96,010
+1,690
+2% +$60.4K ﹤0.01% 1208
2018
Q4
$2.7M Sell
94,320
-5,613
-6% -$160K ﹤0.01% 1246
2018
Q3
$4.43M Buy
99,933
+7,350
+8% +$326K ﹤0.01% 1158
2018
Q2
$5.44M Buy
92,583
+47,850
+107% +$2.81M ﹤0.01% 1045
2018
Q1
$2.05M Buy
44,733
+42,795
+2,208% +$1.96M ﹤0.01% 1452
2017
Q4
$45K Hold
1,938
﹤0.01% 2991
2017
Q3
$34K Buy
1,938
+300
+18% +$5.26K ﹤0.01% 3089
2017
Q2
$26K Hold
1,638
﹤0.01% 3135
2017
Q1
$36K Buy
+1,638
New +$36K ﹤0.01% 2927